Contrast-enhanced echocardiography with transcranial doppler is the method of choice for PFO diagnosis, while transesophageal echocardiography guides percutaneous closure.
This consensus statement provides standardized recommendations for the use of echocardiography and multimodality imaging in the diagnosis, procedural guidance, and follow-up of patent foramen ovale.
Abstract Patent foramen ovale (PFO) is a congenital heart anomaly potentially responsible of paradoxical embolism, enhancing the risk of stroke, especially in young adults. Contrast-enhanced (c-) echocardiography associated with c-transcranial doppler is the method of choice for PFO diagnosis. Transesophageal echocardiography plays a pivotal role for PFO’s anatomical characterization; besides, it serves for guidance during percutaneous closure. A multimodality imaging approach is advised for evaluating residual shunt after percutaneous procedures.
Manganaro et al. (Fri,) conducted a review in Patent foramen ovale (PFO). Echocardiography was evaluated. Contrast-enhanced echocardiography with transcranial doppler is the method of choice for PFO diagnosis, while transesophageal echocardiography guides percutaneous closure.